Vandetanib
-
Catalog number1751-100
-
PricePlease ask
-
Size100 mg
-
-
Alternative_nameN-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; ZD6474, Zactima
-
DescriptionA potent inhibitor of kinase insert domain-containing receptor [KDR/vascular endothelial growth factor receptor (VEGFR) 2] tyrosine kinase activity (IC₅₀ = 40 nM). This compound also inhibits fms-like tyrosine kinase 4 (VEGFR3, IC₅₀ = 110 nM) and epidermal growth factor receptor (EGFR/HER1, IC₅₀ = 500 nM) but shows selectivity relating to a range of other tyrosine and serine-threonine kinases.
-
CAS Number443913-73-3
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₂H₂₄BrFN₄O₂
-
Molecular Weight475.35
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (30 mg/ml) or EtOH (10 mg/ml)
-
HandlingProtect from air and moisture
-
Tag LineA potent VEGFR kinase inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
MDL NumberMFCD07772346
-
PubChem CID3081361
-
SMILESCN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC
-
InChiInChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)
-
InChi KeyUHTHHESEBZOYNR-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameVandetanib
-
Alternative nameVandetanib
-